Final Guidance Clarifies HDE Process, ‘Probable Benefit’
Executive Summary
The US FDA has finalized a guidance document on the humanitarian device exemption process. The revision brings the document in line with requirements of the 21st Century Cures Act.
You may also be interested in...
New FDA Guidance Expands HUD Patient Limit
Devices to treat diseases and conditions affecting many more Americans are eligible for Humanitarian Use Device status under a new guidance document.
Pediatric Scoliosis Device Nabs HDE Approval
The US FDA has approved Zimmer Biomet’s Tether device, which is the first device of its type cleared to treat children with a form of spinal curvature. It's also the first pediatric spinal device to net Humanitarian Device Exemption approval from the agency in 15 years, the company says.
US FDA Tackles HDE 'Probable Benefits' Question In Draft Guidance
In accordance with the 21st Century Cures Act, FDA has published a draft guidance on how it will assess devices intended for orphan diseases under the humanitarian device exemption pathway. A key part of the guidance attempts to address the agencies thinking on what is considered probable benefit.